NCT03792958 2022-11-14
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
AnewPharma
Phase 1 Unknown
Clinical Trials
7 trialsNCT04328506 2021-11-26
Bioequivalency Study of CM082 Tablet in Healthy Volunteers
AnewPharma
Phase 1 Completed
NCT03095040 2021-02-08
CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma
AnewPharma
Phase 3 Unknown
NCT03904719 2020-07-09
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
AnewPharma
Phase 2 Unknown
NCT04126668 2020-05-21
A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers
AnewPharma
Phase 1 Completed
NCT01863485 2019-07-05
Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
AnewPharma
Phase 1 Completed
NCT03286244 2019-02-21
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer
AnewPharma
Phase 1 Unknown